We Have Better Obesity Medications, but Access Is Lagging
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
Ted Kyle, RPh, MBA
Ted Kyle, RPh, MBA, is founder of ConscienHealth, chair of The Obesity Society’s Advocacy Committee, and serves on the Steering Committee for the STOP Obesity Alliance and the Board of Directors for the Obesity Action Coalition.
